-
Abbud RA, Finegan CK, Guay LA, Rich EA, 1995: Enhanced production of human immunodeficiency virus type 1 by in vitroinfected alveolar macrophages from otherwise healthy cigarette smokers[J]. J Infect Dis, 172, 859-863. doi: 10.1093/infdis/172.3.859
-
Ahn J, 2016: Functional organization of human SAMHD1 and mechanisms of HIV-1 restriction[J]. Biol Chem, 397, 373-379.
-
Apolloni A, Meredith LW, Suhrbier A, Kiernan R, Harrich D, 2007: The HIV-1 Tat protein stimulates reverse transcription in vitro[J]. Curr HIV Res, 5, 473-483.
-
Apolloni A, Lin MH, Sivakumaran H, Li D, Kershaw MH, Harrich D, 2013: A mutant Tat protein provides strong protection from HIV-1 infection in human CD4? T cells[J]. Hum Gene Ther, 24, 270-282.
-
Bauer G, Anderson JS (2014) Gene therapy vectors. In: Gene therapy for HIV. Springer, pp 27–33
-
Braun SE, Taube R, Zhu Q, Wong FE, Murakami A, Kamau E, Dwyer M, Qiu G, Daigle J, Carville A, Johnson RP, Marasco WA, 2012: In vivo selection of CD4(+) T cells transduced with a gamma-retroviral vector expressing a single-chain intrabody targeting HIV-1 tat[J]. Hum Gene Ther, 23, 917-931. doi: 10.1089/hum.2011.184
-
Connor RI, Chen BK, Choe S, Landau NR, 1995: Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes[J]. Virology, 206, 935-944. doi: 10.1006/viro.1995.1016
-
Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ, 2004: A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev[J]. Virology, 330, 471-480. doi: 10.1016/j.virol.2004.09.039
-
Forestell SP, Dando JS, Bohnlein E, Rigg RJ, 1996: Improved detection of replication-competent retrovirus[J]. J Virol Methods, 60, 171-178. doi: 10.1016/0166-0934(96)02052-6
-
Guo J, Wang W, Yu D, Wu Y, 2011: Spinoculation triggers dynamic actin and cofilin activity that facilitates HIV-1 infection of transformed and resting CD4 T cells[J]. J Virol, 85, 9824-9833. doi: 10.1128/JVI.05170-11
-
Harrich D, Ulich C, Garcia-Martinez LF, Gaynor RB, 1997: Tat is required for efficient HIV-1 reverse transcription[J]. EMBO J, 16, 1224-1235. doi: 10.1093/emboj/16.6.1224
-
He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR, 1995: Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity[J]. J Virol, 69, 6705-6711.
-
Hulme AE, Perez O, Hope TJ, 2011: Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription[J]. Proc Natl Acad Sci USA, 108, 9975-9980. doi: 10.1073/pnas.1014522108
-
Jin H, Li D, Sivakumaran H, Lor M, Rustanti L, Cloonan N, Wani S, Harrich D (2016) Shutdown of HIV-1 transcription in T cells by nullbasic, a mutant Tat protein. MBio 7: e00518-16
-
Kamori D, Ueno T, 2017: HIV-1 tat and viral latency: what we can learn from naturally occurring sequence variations[J]. Front Microbiol, 8, 80-.
-
Kang W, Marasco WA, Tong HI, Byron MM, Wu C, Shi Y, Sun S, Sun Y, Lu Y, 2014: Anti-tat Hutat2: Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophages[J]. J Neuroinflammation, 11, 195-. doi: 10.1186/s12974-014-0195-2
-
Knight S, Zhang F, Mueller-Kuller U, Bokhoven M, Gupta A, Broughton T, Sha S, Antoniou MN, Brendel C, Grez M, Thrasher AJ, Collins M, Takeuchi Y, 2012: Safer, silencingresistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing[J]. J Virol, 86, 9088-9095. doi: 10.1128/JVI.00485-12
-
Lin MH, Sivakumaran H, Apolloni A, Wei T, Jans DA, Harrich D, 2012: Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV Rev trafficking[J]. PLoS ONE, 7, e51466-. doi: 10.1371/journal.pone.0051466
-
Lin MH, Sivakumaran H, Jones A, Li D, Harper C, Wei T, Jin H, Rustanti L, Meunier FA, Spann K, Harrich D, 2014: A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1[J]. Retrovirology, 11, 121-. doi: 10.1186/s12977-014-0121-9
-
Lin MH, Apolloni A, Cutillas V, Sivakumaran H, Martin S, Li D, Wei T, Wang R, Jin H, Spann K, Harrich D, 2015: A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex[J]. J Virol, 89, 4827-4836. doi: 10.1128/JVI.03440-14
-
Marasco WA, LaVecchio J, Winkler A, 1999: Human anti-HIV-1 Tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS[J]. J Immunol Methods, 231, 223-238. doi: 10.1016/S0022-1759(99)00159-3
-
Meredith LW, Sivakumaran H, Major L, Suhrbier A, Harrich D, 2009: Potent inhibition of HIV-1 replication by a Tat mutant[J]. PLoS ONE, 4, e7769-. doi: 10.1371/journal.pone.0007769
-
Mhashilkar AM, Bagley J, Chen S, Szilvay A, Helland D, Marasco W, 1995a: Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies[J]. EMBO J, 14, 1542-.
-
Mhashilkar AM, Bagley J, Chen SY, Szilvay AM, Helland DG, Marasco WA, 1995b: Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies[J]. EMBO J, 14, 1542-1551.
-
Mhashilkar AM, LaVecchio J, Eberhardt B, Porter-Brooks J, Boisot S, Dove JH, Pumphrey C, Li X, Weissmahr RN, Ring DB, Ramstedt U, Marasco WA, 1999: Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies[J]. Hum Gene Ther, 10, 1453-1467. doi: 10.1089/10430349950017798
-
Naldini L, Verma IM, 2000: Lentiviral vectors[J]. Adv Virus Res, 55, 599-609. doi: 10.1016/S0065-3527(00)55020-9
-
Okitsu T, Kobayashi N, Totsugawa T, Maruyama M, Noguchi H, Watanabe T, Matsumura T, Fujiwara T, Tanaka N, 2003: Lentiviral vector mediated gene delivery into non-dividing isolated islet cells[J]. Transplant Proc, 35, 483-. doi: 10.1016/S0041-1345(02)03785-5
-
Pearson L, Garcia J, Wu F, Modesti N, Nelson J, Gaynor R, 1990: A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat[J]. Proc Natl Acad Sci USA, 87, 5079-5083. doi: 10.1073/pnas.87.13.5079
-
Robertson-Anderson RM, Wang J, Edgcomb SP, Carmel AB, Williamson JR, Millar DP, 2011: Single-molecule studies reveal that DEAD box protein DDX1 promotes oligomerization of HIV-1 Rev on the Rev response element[J]. J Mol Biol, 410, 959-971. doi: 10.1016/j.jmb.2011.04.026
-
Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre JD, Banchereau J, Levy Y, Seddiki N, 2015: Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1[J]. AIDS, 29, 519-530.
-
Ryan MD, King AM, Thomas GP, 1991: Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence[J]. J Gen Virol, 72, 2727-2732. doi: 10.1099/0022-1317-72-11-2727
-
Schambach A, Zychlinski D, Ehrnstroem B, Baum C, 2013: Biosafety features of lentiviral vectors[J]. Hum Gene Ther, 24, 132-142. doi: 10.1089/hum.2012.229
-
Taylor MP, Koyuncu OO, Enquist LW, 2011: Subversion of the actin cytoskeleton during viral infection[J]. Nat Rev Microbiol, 9, 427-439. doi: 10.1038/nrmicro2574
-
Ulich C, Harrich D, Estes P, Gaynor RB, 1996: Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins[J]. J Virol, 70, 4871-4876.
-
Varmus HE, 1982: Form and function of retroviral proviruses[J]. Science, 216, 812-820. doi: 10.1126/science.6177038
-
Varmus H, 1988: Retroviruses[J]. Science, 240, 1427-1435. doi: 10.1126/science.3287617
-
Zhou M, Deng L, Kashanchi F, Brady JN, Shatkin AJ, Kumar A, 2003: The Tat/TAR-dependent phosphorylation of RNA polymerase Ⅱ C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA[J]. Proc Natl Acad Sci USA, 100, 12666-12671. doi: 10.1073/pnas.1835726100
-
Zufferey R, Donello JE, Trono D, Hope TJ, 1999: Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors[J]. J Virol, 73, 2886-2892.